Psilocybin prompts organised shifts in brain activity, study finds
A new study challenges the prevailing view that psychedelics cause brain chaos. Researchers at Monash University found that psilocybin produces organised, meaningful changes in brain activity rather than random disruption. This reframes how scientists understand why psychedelic experiences can be profound and potentially therapeutic.
In the PsiConnect study, 62 participants received 19 milligrams of psilocybin and had their brains scanned whilst meditating, listening to music, and watching videos. The analysis revealed that sensory brain regions lost influence to associative regions controlling imagination and self-perception, whilst connections between brain networks strengthened even as connections within networks weakened. Half the participants ranked the experience amongst the most meaningful of their lives, suggesting the brain's reorganisation correlates with psychological significance rather than disarray.
- Psilocybin reorganises brain networks into order, not chaos
- Sensory regions weaken while associative regions controlling imagination strengthen
- Study participants found the experience profoundly meaningful
New here? Start with this
Psilocybin is a naturally occurring substance found in certain mushrooms that produces hallucinogenic effects. The prevailing scientific view has been that psychedelics such as psilocybin disrupt brain activity, causing chaos and disorder.
A new study from Monash University challenges this understanding. Researchers scanned the brains of 62 participants who had taken psilocybin whilst they meditated, listened to music, and watched videos. They found that the drug reorganised brain activity in structured ways: the areas that process sights and sounds became less influential, whilst areas linked to imagination and self-awareness became more active, and different parts of the brain connected more strongly to each other.
The findings suggest psychedelics alter the brain in organised, measurable ways rather than causing randomness. Half the participants described the experience as among the most meaningful of their lives, indicating the brain's reorganisation relates to the psychological significance of the experience. This could reshape how scientists understand and potentially treat conditions using these substances.
Both sides, in good faith
The strongest fair case each way — we don't pick a winner.
The case for
This research demonstrates that psilocybin produces organised neural reorganisation rather than random disruption, fundamentally reframing our understanding of how these compounds work. The correlation between structured brain changes and participants' reports of profound meaning suggests a genuine biological mechanism underlying therapeutic potential, warranting accelerated investigation for conditions like depression and PTSD where current treatments are limited.
The case against
Whilst promising, this preliminary evidence from 62 participants cannot establish therapeutic efficacy or guide clinical practice. The correlation between subjective meaningfulness and brain reorganisation does not prove causation or demonstrate safety and effectiveness in clinical settings. Responsible science requires larger-scale, longer-duration randomised controlled trials with objective clinical endpoints before psilocybin can be recommended as a therapy.
Read the full article at the source →
Originally published by Ars Technica as “One with the world? A new look at brains transformed by psychedelics.”.